Condition: Sarcoma, Ewing · Sponsor: Istituto Ortopedico Rizzoli
The study involves blood samples from patients with Ewing's sarcoma to identify circulating biomarkers as a tool for the preclinical validation of innovative therapeutic approaches
This description comes directly from the study's public registry record.
Katia Scotlandi, MSc · 39 051 6366760 · katia.scotlandi@ior.it
Always discuss trial participation with your own doctor first.
| Istituto ortopedico Rizzoli Laboratorio di Ricerc Oncologica e Genomica funzioanle | Bologna, BO, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07685405